4//SEC Filing
CELLI FRANK E. 4
Accession 0001104659-21-039256
CIK 0001590383other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 6:14 PM ET
Size
6.1 KB
Accession
0001104659-21-039256
Insider Transaction Report
Form 4
CELLI FRANK E.
DirectorChairman and CEO
Transactions
- Sale
Common Stock, par value $0.0001
2021-03-18$2.28/sh−29,774$67,894→ 565,710 total(indirect: By Trust)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2021.
- [F2]This transaction was executed in multiple trades at prices ranging from $2.23 to $2.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Does not include 1,467,777 shares of common stock held by Frank E. Celli, individually.
- [F4]The securities reported above were not sold by the reporting person but by a family trust of which the reporting person's wife is the sole trustee and of which Frank E. Celli is not a beneficiary. Frank E. Celli disavows voting and dispositive control over the securities held by such trust. The Trust sold the shares for estate planning purposes.
Documents
Issuer
BIOHITECH GLOBAL, INC.
CIK 0001590383
Entity typeother
Related Parties
1- filerCIK 0001658037
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 6:14 PM ET
- Size
- 6.1 KB